Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 645

1.

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome.

Schrieks IC, Nozza A, Stähli BE, Buse JB, Henry RR, Malmberg K, Neal B, Nicholls SJ, Rydén L, Mellbin L, Svensson A, Wedel H, Weichert A, Lincoff AM, Tardif JC, Grobbee DE, Schwartz GG.

Diabetes Care. 2018 Jun 14. pii: dc180158. doi: 10.2337/dc18-0158. [Epub ahead of print]

PMID:
29903845
2.

On the prognostic value of post-load glucose in patients with coronary artery disease.

Rydén L, Shahim B, Standl E.

Eur Heart J. 2018 Jun 9. doi: 10.1093/eurheartj/ehy320. [Epub ahead of print] No abstract available.

PMID:
29893842
3.

Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.

Larsson AM, Jansson S, Bendahl PO, Levin Tykjaer Jörgensen C, Loman N, Graffman C, Lundgren L, Aaltonen K, Rydén L.

Breast Cancer Res. 2018 Jun 8;20(1):48. doi: 10.1186/s13058-018-0976-0.

4.

Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants.

Theodorakis MJ, Coleman RL, Feng H, Chan J, Chiasson JL, Ge J, Gerstein HC, Huo Y, Lang Z, McMurray JJ, Rydén L, Schröder S, Tendera M, Tuomilehto J, Yang W, Hu D, Pan C, Holman RR; ACE Study Group.

Am Heart J. 2018 May;199:170-175. doi: 10.1016/j.ahj.2017.09.001. Epub 2017 Sep 8. No abstract available.

PMID:
29754657
5.

Homeostasis Model Assessment of Insulin Resistance and Survival in Patients with Diabetes and Acute Coronary Syndrome.

Stähli BE, Nozza A, Schrieks IC, Buse JB, Malmberg K, Mellbin L, Neal B, Nicholls SJ, Rydén L, Svensson A, Wedel H, Weichert A, Lincoff AM, Grobbee DE, Tardif JC, Schwartz GG.

J Clin Endocrinol Metab. 2018 Apr 6. doi: 10.1210/jc.2017-02772. [Epub ahead of print]

PMID:
29659887
6.

Severe Periodontitis Is Associated with Myocardial Infarction in Females.

Nordendahl E, Gustafsson A, Norhammar A, Näsman P, Rydén L, Kjellström B; PAROKRANK Steering Committee.

J Dent Res. 2018 Mar 1:22034518765735. doi: 10.1177/0022034518765735. [Epub ahead of print]

PMID:
29596754
7.
8.

Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling.

Roswall P, Bocci M, Bartoschek M, Li H, Kristiansen G, Jansson S, Lehn S, Sjölund J, Reid S, Larsson C, Eriksson P, Anderberg C, Cortez E, Saal LH, Orsmark-Pietras C, Cordero E, Haller BK, Häkkinen J, Burvenich IJG, Lim E, Orimo A, Höglund M, Rydén L, Moch H, Scott AM, Eriksson U, Pietras K.

Nat Med. 2018 May;24(4):463-473. doi: 10.1038/nm.4494. Epub 2018 Mar 12.

PMID:
29529015
9.

Genetic variation in FOXO3 is associated with self-rated health in a population-based sample of older individuals.

Zettergren A, Kern S, Rydén L, Östling S, Blennow K, Zetterberg H, Falk H, Skoog I.

J Gerontol A Biol Sci Med Sci. 2018 Feb 5. doi: 10.1093/gerona/gly021. [Epub ahead of print]

PMID:
29415201
10.

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence.

Jansson S, Aaltonen K, Bendahl PO, Falck AK, Karlsson M, Pietras K, Rydén L.

Breast Cancer Res Treat. 2018 Jun;169(2):231-241. doi: 10.1007/s10549-018-4664-7. Epub 2018 Jan 29.

11.
12.

Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative.

Rydén L, Loman N, Larsson C, Hegardt C, Vallon-Christersson J, Malmberg M, Lindman H, Ehinger A, Saal LH, Borg Å.

Br J Surg. 2018 Jan;105(2):e158-e168. doi: 10.1002/bjs.10741.

13.

Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention).

Gerstein HC, Jung H, Rydén L, Diaz R, Gilbert RE, Yusuf S; ORIGIN Investigators.

Circulation. 2018 Jan 2;137(1):88-90. doi: 10.1161/CIRCULATIONAHA.117.030924. No abstract available.

PMID:
29279340
14.

Anaemia and iron deficiency in heart failure: epidemiological gaps, diagnostic challenges and therapeutic barriers in sub-Saharan Africa.

Makubi A, Lwakatare J, Ogah OS, Rydén L, Lund LH, Makani J.

Cardiovasc J Afr. 2017 Sep/Oct;28(5):331-337. doi: 10.5830/CVJA-2017-001. Review.

15.

Correction to: Updates on cardiovascular outcome trials in diabetes.

Schnell O, Rydén L, Standl E, Ceriello A; D&CVD EASD Study Group.

Cardiovasc Diabetol. 2017 Nov 15;16(1):150. doi: 10.1186/s12933-017-0633-4.

16.

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators.

Lancet. 2017 Nov 10. pii: S0140-6736(17)32409-1. doi: 10.1016/S0140-6736(17)32409-1. [Epub ahead of print]

17.

Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes.

Savonitto S, Morici N, Nozza A, Cosentino F, Perrone Filardi P, Murena E, Morocutti G, Ferri M, Cavallini C, Eijkemans MJ, Stähli BE, Schrieks IC, Toyama T, Lambers Heerspink HJ, Malmberg K, Schwartz GG, Lincoff AM, Ryden L, Tardif JC, Grobbee DE.

Diab Vasc Dis Res. 2018 Jan;15(1):14-23. doi: 10.1177/1479164117735493. Epub 2017 Oct 20.

PMID:
29052439
18.

Updates on cardiovascular outcome trials in diabetes.

Schnell O, Rydén L, Standl E, Ceriello A; D&CVD EASD Study Group.

Cardiovasc Diabetol. 2017 Oct 11;16(1):128. doi: 10.1186/s12933-017-0610-y. Review. Erratum in: Cardiovasc Diabetol. 2017 Nov 15;16(1):150.

19.

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.

Holman RR, Coleman RL, Chan JCN, Chiasson JL, Feng H, Ge J, Gerstein HC, Gray R, Huo Y, Lang Z, McMurray JJ, Rydén L, Schröder S, Sun Y, Theodorakis MJ, Tendera M, Tucker L, Tuomilehto J, Wei Y, Yang W, Wang D, Hu D, Pan C; ACE Study Group.

Lancet Diabetes Endocrinol. 2017 Nov;5(11):877-886. doi: 10.1016/S2213-8587(17)30309-1. Epub 2017 Sep 13. Erratum in: Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7.

PMID:
28917545
20.

Fungal coronary embolus while on extracorporeal membrane oxygenation.

Martinez FE, Ryden L, Leaver R, Mendoza J, Havill K.

Anaesth Intensive Care. 2017 Sep;45(5):634-635. No abstract available.

PMID:
28911297
21.

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators.

N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27.

22.

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98.

Alkner S, Jensen MB, Rasmussen BB, Bendahl PO, Fernö M, Rydén L, Mouridsen H; Danish Breast Cancer Cooperative Group.

Breast Cancer Res Treat. 2017 Nov;166(2):481-490. doi: 10.1007/s10549-017-4416-0. Epub 2017 Aug 1.

23.

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.

Bosch J, Eikelboom JW, Connolly SJ, Bruns NC, Lanius V, Yuan F, Misselwitz F, Chen E, Diaz R, Alings M, Lonn EM, Widimsky P, Hori M, Avezum A, Piegas LS, Bhatt DL, Branch KRH, Probstfield JL, Liang Y, Liu L, Zhu J, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Fox KAA, Kakkar A, Parkhomenko AN, Ertl G, Störk S, Keltai K, Keltai M, Ryden L, Dagenais GR, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Ha JW, Tonkin AM, Varigos JD, Lewis BS, Felix C, Yusoff K, Steg PG, Aboyans V, Metsarinne KP, Anand SS, Hart RG, Lamy A, Moayyedi P, Leong DP, Sharma M, Yusuf S.

Can J Cardiol. 2017 Aug;33(8):1027-1035. doi: 10.1016/j.cjca.2017.06.001. Epub 2017 Jun 8. Review.

24.

Nomograms for preoperative prediction of axillary nodal status in breast cancer.

Dihge L, Bendahl PO, Rydén L.

Br J Surg. 2017 Oct;104(11):1494-1505. doi: 10.1002/bjs.10583. Epub 2017 Jul 18.

25.

Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival.

Abrahamsson J, Aaltonen K, Engilbertsson H, Liedberg F, Patschan O, Rydén L, Sjödahl G, Gudjonsson S.

Urol Oncol. 2017 Oct;35(10):606.e9-606.e16. doi: 10.1016/j.urolonc.2017.05.021. Epub 2017 Jul 1.

PMID:
28676151
26.

Tumor tissue protein signatures reflect histological grade of breast cancer.

Skoog P, Ohlsson M, Fernö M, Rydén L, Borrebaeck CAK, Wingren C.

PLoS One. 2017 Jun 26;12(6):e0179775. doi: 10.1371/journal.pone.0179775. eCollection 2017.

27.

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of Cardiology.

Shahim B, De Bacquer D, De Backer G, Gyberg V, Kotseva K, Mellbin L, Schnell O, Tuomilehto J, Wood D, Rydén L.

Diabetes Care. 2017 Sep;40(9):1233-1240. doi: 10.2337/dc17-0245. Epub 2017 Jun 21.

PMID:
28637653
28.

Acute kidney injury-an overview of diagnostic methods and clinical management.

Hertzberg D, Rydén L, Pickering JW, Sartipy U, Holzmann MJ.

Clin Kidney J. 2017 Jun;10(3):323-331. doi: 10.1093/ckj/sfx003. Epub 2017 Mar 15.

29.

Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riddle MC, Rydén L, Xavier D, Atisso CM, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona-Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw J, Sheu WH, Temelkova-Kurktschiev T; REWIND Trial Investigators.

Diabetes Obes Metab. 2018 Jan;20(1):42-49. doi: 10.1111/dom.13028. Epub 2017 Jul 14.

PMID:
28573765
30.

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.

de Boniface J, Frisell J, Andersson Y, Bergkvist L, Ahlgren J, Rydén L, Olofsson Bagge R, Sund M, Johansson H, Lundstedt D; SENOMAC Trialists’ Group.

BMC Cancer. 2017 May 26;17(1):379. doi: 10.1186/s12885-017-3361-y.

31.

New Hope For People With Dysglycemia and Cardiovascular Disease Manifestations: Reduction of Acute Coronary Events With Pioglitazone.

Rydén L, Mellbin L.

Circulation. 2017 May 16;135(20):1894-1896. doi: 10.1161/CIRCULATIONAHA.117.027952. No abstract available.

32.

Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: Insights from the EUROASPIRE IV survey of the European Society of Cardiology.

Wagner M, Wanner C, Kotseva K, Wood D, De Bacquer D, Rydén L, Störk S, Heuschmann PU; EUROASPIRE IV investigators.

Eur J Prev Cardiol. 2017 Jul;24(11):1168-1180. doi: 10.1177/2047487317708891. Epub 2017 May 15.

PMID:
28503987
33.

Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy.

Aaltonen KE, Novosadová V, Bendahl PO, Graffman C, Larsson AM, Rydén L.

Oncotarget. 2017 Jul 11;8(28):45544-45565. doi: 10.18632/oncotarget.17271.

34.

Saliva and plasma levels of cardiac-related biomarkers in post-myocardial infarction patients.

Rathnayake N, Buhlin K, Kjellström B, Klinge B, Löwbeer C, Norhammar A, Rydén L, Sorsa T, Tervahartiala T, Gustafsson A; PAROKRANK Steering Committee.

J Clin Periodontol. 2017 Jul;44(7):692-699. doi: 10.1111/jcpe.12740. Epub 2017 Jun 20.

PMID:
28453865
35.

Corrections needed to 2016 ESC and AHA guidelines on heart failure.

Rydén L, Van de Werf F, Armstrong PW, McGuire DK, Standl E, Peterson ED, Holman RR.

Lancet Diabetes Endocrinol. 2017 May;5(5):325-326. doi: 10.1016/S2213-8587(17)30102-X. Epub 2017 Apr 5. No abstract available. Erratum in: Lancet Diabetes Endocrinol. 2017 Jun;5(6):e4.

PMID:
28395875
36.

The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial.

van Steen SC, Schrieks IC, Hoekstra JB, Lincoff AM, Tardif JC, Mellbin LG, Rydén L, Grobbee DE, DeVries JH; AleCardio study group.

Eur J Prev Cardiol. 2017 May;24(8):858-866. doi: 10.1177/2047487317692664. Epub 2017 Feb 10.

PMID:
28186441
37.

Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.

Ritsinger V, Brismar K, Malmberg K, Mellbin L, Näsman P, Rydén L, Söderberg S, Tenerz Å, Norhammar A.

Diab Vasc Dis Res. 2017 Mar;14(2):77-87. doi: 10.1177/1479164116678156. Epub 2016 Dec 21.

PMID:
28185529
38.

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer.

Paulsson J, Rydén L, Strell C, Frings O, Tobin NP, Fornander T, Bergh J, Landberg G, Stål O, Östman A.

J Pathol Clin Res. 2016 Sep 14;3(1):38-43. doi: 10.1002/cjp2.56. eCollection 2017 Jan.

39.

Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes.

Standl E, Schnell O, McGuire DK, Ceriello A, Rydén L.

Lancet Diabetes Endocrinol. 2017 May;5(5):391-402. doi: 10.1016/S2213-8587(17)30033-5. Epub 2017 Jan 26. Review. Erratum in: Lancet Diabetes Endocrinol. 2017 May;5(5):e3.

PMID:
28131656
40.

Symptoms of depression and their relation to myocardial infarction and periodontitis.

Kjellström B, Gustafsson A, Nordendal E, Norhammar A, Nygren Å, Näsman P, Rydén L, Åsberg M; PAROKRANK steering committee.

Eur J Cardiovasc Nurs. 2017 Aug;16(6):468-474. doi: 10.1177/1474515116686462. Epub 2016 Dec 29.

PMID:
28032516
41.

Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.

Gyberg V, De Bacquer D, Kotseva K, De Backer G, Schnell O, Tuomilehto J, Wood D, Rydén L.

BMJ Open. 2016 Dec 8;6(12):e013835. doi: 10.1136/bmjopen-2016-013835.

42.

Inflammatory cell response to ultra-thin amorphous and crystalline hydroxyapatite surfaces.

Rydén L, Omar O, Johansson A, Jimbo R, Palmquist A, Thomsen P.

J Mater Sci Mater Med. 2017 Jan;28(1):9. Epub 2016 Nov 28.

43.
44.

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.

Magnusson K, Gremel G, Rydén L, Pontén V, Uhlén M, Dimberg A, Jirström K, Pontén F.

BMC Cancer. 2016 Nov 18;16(1):904.

45.

Effects of enhanced external counterpulsation on skeletal muscle gene expression in patients with severe heart failure.

Melin M, Montelius A, Rydén L, Gonon A, Hagerman I, Rullman E.

Clin Physiol Funct Imaging. 2018 Jan;38(1):118-127. doi: 10.1111/cpf.12392. Epub 2016 Oct 26.

PMID:
27782354
46.

Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.

Ehinger A, Malmström P, Bendahl PO, Elston CW, Falck AK, Forsare C, Grabau D, Rydén L, Stål O, Fernö M; South and South-East Swedish Breast Cancer Groups.

Acta Oncol. 2017 Jan;56(1):68-74. doi: 10.1080/0284186X.2016.1237778. Epub 2016 Oct 20.

PMID:
27762648
47.

Current perspectives on cardiovascular outcome trials in diabetes.

Schnell O, Rydén L, Standl E, Ceriello A; D&CVD EASD Study Group.

Cardiovasc Diabetol. 2016 Oct 1;15(1):139. Review.

48.

Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure.

Johansson I, Dahlström U, Edner M, Näsman P, Rydén L, Norhammar A.

J Am Coll Cardiol. 2016 Sep 27;68(13):1404-1416. doi: 10.1016/j.jacc.2016.06.061.

49.

Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.

Kotseva K, De Bacquer D, De Backer G, Rydén L, Jennings C, Gyberg V, Abreu A, Aguiar C, Conde AC, Davletov K, Dilic M, Dolzhenko M, Gaita D, Georgiev B, Gotcheva N, Lalic N, Laucevicius A, Lovic D, Mancas S, Miličić D, Oganov R, Pajak A, Pogosova N, Reiner Ž, Vulic D, Wood D, On Behalf Of The Euroaspire Investigators.

Eur J Prev Cardiol. 2016 Dec;23(18):2007-2018. doi: 10.1177/2047487316667784. Epub 2016 Sep 27.

PMID:
27638542
50.

Oral glucose tolerance testing and cardiovascular disease.

Rydén L, Viveca G, Schnell O, Jaakko T; EUROASPIRE IV investigators.

Lancet Diabetes Endocrinol. 2016 Sep;4(9):732-733. doi: 10.1016/S2213-8587(16)30183-8. No abstract available.

PMID:
27542923

Supplemental Content

Support Center